Bio
Martin Mumenthaler has a PharmD and a PhD in psychopharmacology from the University of Bern, Switzerland. He holds an appointment as Adjunct Professor in the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine where he has been conducting research programs in addiction medicine and psychopharmacology, and teaching and mentoring medical students and residents on a voluntary basis.
Dr. Mumenthaler has also been working in various full-time positions in the pharmaceutical industry as Director in Clinical Development as well as in Medical Affairs, and as a consultant for early-stage pharma- and biotech companies providing advice on designing and conducting clinical trials, and analyzing and interpreting study results, mainly in the field of addiction medicine and pain.
His academic research has focused on the effects of psychoactive drugs on human performance, Aerospace Medicine, Alzheimer’s disease, and addiction medicine, and in these areas he has presented his results internationally and published over twenty-five peer-reviewed scientific articles. He has also served as a reviewer for various scientific journals, and is a member of the Research Society on Alcoholism, and an Associate Fellow of the Aerospace Medical Association.
